BGBUSDT SPOTLong
BGB Idea
BGB Update 1h Timeframe
Market Structure
Overall structure has been bullish since the start of December following a Golden Crossover of the MAs'. Looking on the far left chart, price made a stopover at 4.9 and form a TLres with ma200 acting as dynamic support. Upon breakout of the TL, price rally upwards creating series of HHs&HLs with NATH at 8.5. Exhausted, price makes a LH, breaks last HL then retrace to make the next LH, this structure validates the shift. Lined LHs to make the TLresistance. Upon breakdown from ma100, ma200 acts as support again, then price recover a bit but face rejection on the ma100+TL and this forms the next LH. Little conso on the ma200 line then drop a bit, take out LQ and make new LL. Price moves up but this time face rejection on the ma200 and make the latest LH, price range until bouncing on the TLres again follows by MA Death Crossover.
Nearest untested Demand Zone would be the OB at $5 area. With inducement sitting at prev LL, the ideal move for now is to mitigate this zone.
Market Structure
Overall structure has been bullish since the start of December following a Golden Crossover of the MAs'. Looking on the far left chart, price made a stopover at 4.9 and form a TLres with ma200 acting as dynamic support. Upon breakout of the TL, price rally upwards creating series of HHs&HLs with NATH at 8.5. Exhausted, price makes a LH, breaks last HL then retrace to make the next LH, this structure validates the shift. Lined LHs to make the TLresistance. Upon breakdown from ma100, ma200 acts as support again, then price recover a bit but face rejection on the ma100+TL and this forms the next LH. Little conso on the ma200 line then drop a bit, take out LQ and make new LL. Price moves up but this time face rejection on the ma200 and make the latest LH, price range until bouncing on the TLres again follows by MA Death Crossover.
Nearest untested Demand Zone would be the OB at $5 area. With inducement sitting at prev LL, the ideal move for now is to mitigate this zone.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.